Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EMEA (REGIONAL)

Denmark

Egypt

France

Germany

Hungary

Italy

Netherlands

Poland

Portugal

Romania

South Africa

Spain

Sweden

Tunisia

Turkey

Ukraine

United Kingdom

ASIA PACIFIC

Asia Pacific (Regional)

China

India

Indonesia

Japan

Korea

Malaysia

Philippines

Publications

OBJECTIVES

Bacterial bronchopneumonia caused by Mannheimia haemolytica, Pasteurella multocida and/or Histophilus somni remains a major cause of morbidity and mortality in beef and dairy cattle worldwide. Among antimicrobials licensed for BP treatment, florfenicol is often selected as first line antimicrobial because of its high level of efficacy. A systematic review was conducted to evaluate sensitivity to florfenicol (FFE) of M. haemolytica, P. multocida, and H. somni recently isolated from cattle in Europe, USA and Canada.

MATERIALS AND METHODS

PRISMA guidelines were followed. Original articles in English, French and Italian published between 2014 and 2019 were searched in CAB (Commonwealth Agricultural Bureau) Abstracts and PubMed/MEDLINE databases on Feb 2nd, 2019. The following keywords were used for the search: (antibiotic resistance OR antimicrobial resistance) AND (Mannheimia haemolytica OR Pasteurella multocida OR Histophilus somni). Articles were included in the review based on the following criteria: clinical isolates originating from Europe, USA or Canada; sensitivity/resistance defined based on CLSI guidelines; reporting phenotypic resistance against FFE; clinical isolates obtained after 2010

 

RESULTS

Proportions of M. haemolytica, P. multocida and H. somni isolates sensitive to florfenicol in Europe, USA and Canada (based on 12 recent original scientific articles)

 

  • Susceptibility to FFE was high in P. multocida and H. somni strains isolated in Europe, US or Canada during the last 5 to 10 years (>86%).

 

  • Susceptibility to FFE was also high in M. haemolytica isolated from Canada and Europe. However, it was sometimes reduced in M. haemolytica recovered from cattle previously exposed to antimicrobials as curative or preventive treatment (e.g. metaphylaxis) in the US.

CONCLUSIONS

This systematic review provides the most up-to-date information available in the scientific literature regarding susceptibility to florfenicol of M. haemolytica, P. multocida, and H. somni recently isolated from cattle in Europe, USA and Canada.

The relatively low prevalence of Pasteurellaceae resistant to florfenicol indicates that genes conferring resistance to florfenicol such as floR or fexA are not widely distributed among Pasteurellaceae originating from cattle and that new mechanism of resistances to florfenicol are probably slow to develop.

Don´t hesitate to read the rest of our publicatons and improve your knowledge about ruminats and their health!

Share this publication:

Publication file:

Download publication
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.